Jeffrey E. Russel

Array ( [id] => 4359909 [patent_doc_number] => 06255283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (TNF)' [patent_app_type] => 1 [patent_app_number] => 9/381737 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1132 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255283.pdf [firstpage_image] =>[orig_patent_app_number] => 381737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1448849 [patent_doc_number] => 06455025 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Polysaccharide-peptide derivatives' [patent_app_type] => B1 [patent_app_number] => 09/331405 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6000 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455025.pdf [firstpage_image] =>[orig_patent_app_number] => 09331405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548529 [patent_doc_number] => 06399071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Neoglycoproteins' [patent_app_type] => B1 [patent_app_number] => 09/403111 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17779 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399071.pdf [firstpage_image] =>[orig_patent_app_number] => 09403111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4337534 [patent_doc_number] => 06333308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Cyclic peptide derivatives' [patent_app_type] => 1 [patent_app_number] => 9/341552 [patent_app_country] => US [patent_app_date] => 1999-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6713 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 304 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333308.pdf [firstpage_image] =>[orig_patent_app_number] => 341552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294008 [patent_doc_number] => 06180598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Covalently modified hemoglobin having low temperature-dependent oxygen-binding function' [patent_app_type] => 1 [patent_app_number] => 9/413933 [patent_app_country] => US [patent_app_date] => 1999-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5237 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180598.pdf [firstpage_image] =>[orig_patent_app_number] => 413933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360972 [patent_doc_number] => 06569685 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Protein fingerprint system and related methods' [patent_app_type] => B1 [patent_app_number] => 09/412732 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 36 [patent_no_of_words] => 11485 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 368 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569685.pdf [firstpage_image] =>[orig_patent_app_number] => 09412732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382866 [patent_doc_number] => 06262021 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Use of substances having oxytocin activity for preparation of medicaments for wound healing' [patent_app_type] => 1 [patent_app_number] => 9/381799 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5785 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262021.pdf [firstpage_image] =>[orig_patent_app_number] => 381799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274609 [patent_doc_number] => 06323311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Synthesis of insulin derivatives' [patent_app_type] => 1 [patent_app_number] => 9/400942 [patent_app_country] => US [patent_app_date] => 1999-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 8122 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323311.pdf [firstpage_image] =>[orig_patent_app_number] => 400942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391865 [patent_doc_number] => 06544949 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Analogs of parathyroid hormone' [patent_app_type] => B1 [patent_app_number] => 09/399499 [patent_app_country] => US [patent_app_date] => 1999-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16317 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544949.pdf [firstpage_image] =>[orig_patent_app_number] => 09399499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304251 [patent_doc_number] => 06187751 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Biologically active peptide of ob protein' [patent_app_type] => 1 [patent_app_number] => 9/391799 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6012 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187751.pdf [firstpage_image] =>[orig_patent_app_number] => 391799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265065 [patent_doc_number] => 06245320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Inhibition of mucin release from airway goblet cells by polycationic peptides' [patent_app_type] => 1 [patent_app_number] => 9/387501 [patent_app_country] => US [patent_app_date] => 1999-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5903 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245320.pdf [firstpage_image] =>[orig_patent_app_number] => 387501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1585939 [patent_doc_number] => 06358917 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Cosmetic use of botulinum toxin for treatment of downturned mouth' [patent_app_type] => B1 [patent_app_number] => 09/382002 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2185 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358917.pdf [firstpage_image] =>[orig_patent_app_number] => 09382002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311524 [patent_doc_number] => 06316406 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Depsipeptides containing N-substituted glycine residue' [patent_app_type] => 1 [patent_app_number] => 9/379614 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8767 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 416 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316406.pdf [firstpage_image] =>[orig_patent_app_number] => 379614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1386981 [patent_doc_number] => 06552167 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Polyamide chains of precise length' [patent_app_type] => B1 [patent_app_number] => 09/379297 [patent_app_country] => US [patent_app_date] => 1999-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23086 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552167.pdf [firstpage_image] =>[orig_patent_app_number] => 09379297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420431 [patent_doc_number] => 06177407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Methods to increase blood flow to ischemic tissue' [patent_app_type] => 1 [patent_app_number] => 9/373962 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8275 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177407.pdf [firstpage_image] =>[orig_patent_app_number] => 373962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931193 [patent_doc_number] => 06979697 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-27 [patent_title] => 'Regulation of substrate activity' [patent_app_type] => utility [patent_app_number] => 09/744658 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7416 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979697.pdf [firstpage_image] =>[orig_patent_app_number] => 09744658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477664 [patent_doc_number] => 06451569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Synthetic molecules that specifically react with target sequences' [patent_app_type] => B1 [patent_app_number] => 09/372338 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10846 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451569.pdf [firstpage_image] =>[orig_patent_app_number] => 09372338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410021 [patent_doc_number] => 06310073 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Methods and compositions to treat glycosaminoglycan-associated molecular interactions' [patent_app_type] => 1 [patent_app_number] => 9/362505 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 28 [patent_no_of_words] => 13245 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310073.pdf [firstpage_image] =>[orig_patent_app_number] => 362505 [rel_patent_id] =>[rel_patent_doc_number] =>)